Compare Global X CleanTech (CTEC) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X CleanTech vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Global X CleanTech trades at $55.45 (market cap $24.57M), while Halozyme Therapeutics Inc. Common Stock trades at $110.94 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 512× Global X CleanTech's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Global X CleanTech nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X CleanTech for 42 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| CTEC | HALO | |
|---|---|---|
Market Cap | $24.57M | $12.58B |
Volume | 1,220 | 2,179,278 |
Sector | Sector/Thematic | Health |
52-Week High | $78.11 | $115.22 |
52-Week Low | $50.82 | $61.63 |
Typical Hold Time | 42 Days | 0 Days |
Enterprise Value | — | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Global X CleanTech
CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.
Read more on CTEC →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
